Fundz

China Pharma Holdings, Inc. closes a $5.0 million registered direct offering aimed at financing its working capital and general corporate purposes.

PUBLIC · CPHIJul 23, 2026

Amount Raised

$5 Million

Round Type

Post-IPO Equity

ChinaManufacturingBiotechnologyPharmaceutical

Description

China Pharma Holdings, Inc. has successfully closed its registered direct offering of 2,500,000 shares at a price of $2.00 per share. This offering generated gross proceeds of $5 million, which will be used for working capital. The offering was facilitated by FT Global Capital, Inc

Quick answer

China Pharma Holdings raised $5 Million in a Post-IPO Equity round, dated July 23, 2026. China Pharma Holdings is based in China.

How much did China Pharma Holdings raise?
China Pharma Holdings raised $5 Million in a Post-IPO Equity round on July 23, 2026.
What does China Pharma Holdings do?
China Pharma Holdings, Inc. (NYSE American: CPHI) is a specialty pharmaceutical company that develops, manufactures, and markets a diversified portfolio of products, focusing on conditions with high incidence and high..
Where is China Pharma Holdings based and how big is it?
China Pharma Holdings is based in China. Fundz records about 230 employees.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as China Pharma Holdings that raised within 45 days of this round, from Fundz verified event records.

  • Tarsus Pharmaceuticals raised $125M (Post-IPO Equity) on August 6, 2026.
  • GMP Manufacturing Ltd raised $667K (Debt Financing) on July 8, 2026.
  • CurifyLabs raised $14M (Series A) on July 6, 2026.
  • Ascendia Pharmaceuticals raised $4.1M on June 26, 2026.
  • Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
  • Qilin Zhengwei raised an undisclosed amount (Series A) on September 3, 2026.

Who to call at China Pharma Holdings, and when

A new round usually means China Pharma Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day China Pharma Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at China Pharma Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at China Pharma Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

China Pharma Holdings

Location

China

About

China Pharma Holdings, Inc. (NYSE American: CPHI) is a specialty pharmaceutical company that develops, manufactures, and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit www.chinapharmaholdings.com. The Company routinely posts important information on its website.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment China Pharma Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for China Pharma Holdings's next move

See what Strategic adds

China Pharma Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.